Cell-Derived Nanoparticles Decrease Infectiousness of SARS-CoV-2

A group of researchers found that nanoparticles called “extracellular vesicles” (EVs) released by cells have the ability to reduce the infectiousness of SARS-CoV-2, including both wild-type and variant strains, as well as possibly other infectious diseases.